Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Direct Meds vs SkinnyRx

By GLP-1 ScorecardUpdated

Direct Meds
Site position #35

Higher grade

SkinnyRx
Site position #285

Lower grade

Score comparison

Direct Meds has the higher recorded score — 77.6/100 to 60.5/100.

Direct Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Direct Meds prices compounded injections and sublingual bottles separately; compare the renewal charge and early cancellation cutoff before choosing a plan.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueDirect Meds +33
85
52
Dose & formulationEven
88
88
Clinical oversightEven
55
55
Labs & monitoringDirect Meds +38
78
40
FulfillmentSkinnyRx +2
80
82
Contract termsDirect Meds +42
80
38
Direct Meds · top barSkinnyRx · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricDirect MedsSkinnyRx
WeighScore77.6/10060.5/100
GradeC+C
Site position#35#285
Semaglutide$249/30 days sublingual · $297/mo injectable$349/mo month-to-month (compounded; the advertised rate is a 12-month prepay)
Tirzepatide$299/30 days sublingual · $399/mo injectable$399/mo month-to-month (compounded; the advertised rate is a 12-month prepay)
CoverageNot publicly listed47 states + DC (not Alabama, Louisiana or Mississippi)
Brand-name accessNot confirmedNot confirmed
Oral / sublingualYesYes
Direct Meds

Site position #35 · C+

FDAWarning letter issued to directmeds.com, Inc. dba DirectMeds in September 2025. See the FDA warning-letter database.

Strengths

  • Injection and sublingual preparations have separately published prices
  • Pricing page advertises medication, evaluation, supplies, shipping and nurse access
  • Both semaglutide and tirzepatide are listed
  • Checked semaglutide campaign states $147 initially, then $297 monthly

What to consider

  • Compounded preparations are not FDA-approved products or assumed equivalent across routes
  • No-subscription FAQ wording conflicts with the agreement's 30-day recurring charges
  • Renewal cancellation requires 48-hour notice; initial-order cancellation has a separate conditional 24-hour window
  • Assigned prescribing practice, dispensing pharmacy and selected longer-plan total need confirmation
  • Checked campaign excludes Mississippi and Louisiana; confirm state eligibility
SkinnyRx

Site position #285 · C

FDAWarning letter issued to Lean Rx, Inc. dba SkinnyRx in February 2026. See the FDA warning-letter database.

Strengths

  • Both molecules by both routes: semaglutide and tirzepatide as injections, tirzepatide as a tablet on the identical term ladder, plus a separate low-dose line with its own page
  • The full term ladder — every rung, both molecules — is on the product page before any medical intake, which is more than most of this ranking discloses after one
  • Terms are concrete rather than gestural: free shipping, unlimited provider messaging, a 90-day money-back guarantee, and no charge at all if a clinician finds you ineligible
  • The state exclusions are published rather than discovered at checkout — 47 states plus DC, with Alabama, Louisiana and Mississippi named

What to consider

  • FDA issued Lean Rx, Inc. dba SkinnyRx a warning letter in February 2026; the letter is public in FDA's warning-letter database
  • The advertised "$199/mo" and "$299/mo" are twelve-month rates by construction — the site's own price code drops the one-month rung before picking a headline — so the monthly rates are $349 semaglutide and $399 tirzepatide
  • Those rungs are a single up-front charge, not a smaller bill: $2,388 for the semaglutide year and $3,588 for the tirzepatide year, taken on day one and auto-renewing each term, with membership fees stated as non-refundable
  • The microdose line costs the SAME as full dose at every term the two share, and its floor is HIGHER — $229 against $199 on semaglutide, $319 against $299 on tirzepatide — because the low-dose plans stop at eight months rather than twelve
  • No brand-name product is actually purchasable: Ozempic, Wegovy, Mounjaro and Zepbound all carry a null price, both pill products are out of stock, and the only priced brand path is a $49/mo membership plus a medication cost that is never published
  • Compounded semaglutide and tirzepatide are not FDA-approved and are not generic equivalents of the brand drugs
  • Fulfillment is disclosed only as a category: "503A pharmacies", never a facility, never a city, and no medical director is named for the program anywhere on the site — so the two things that decide whether a compounded vial is trustworthy are the two things this seller does not publish
  • Labs and monitoring are simply absent from the site: nothing states whether baseline or follow-up bloodwork is required, included in the membership, or billed on top of it
  • Alabama, Louisiana and Mississippi are excluded, so three states' readers cannot buy at any price on this ladder

Featured provider

Direct Meds

Direct Meds scores 77.6/100 (C+). Direct Meds prices compounded injections and sublingual bottles separately; compare the renewal charge and early cancellation cutoff before choosing a plan.

Commercial relationships affect this placement. The score comparison above is separate.

FDAWarning letter issued to directmeds.com, Inc. dba DirectMeds in September 2025. See the FDA warning-letter database.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard